Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Renin‐angiotensin system inhibition may leads to lower > 50% increase in SCr compared with other supportive care treatment (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Tonsillectomy plus standard care may leads to higher remission of proteinuria compared with standard care (low certainty).
Tonsillectomy plus standard care may leads to higher remission of haematuria (microscopic) compared with standard care (low certainty).
It is very uncertain whether tonsillectomy plus standard care changes relapse of haematuria (macroscopic) compared with standard care (very low certainty).
Renin‐angiotensin system inhibition showed no clear difference in kidney failure or doubling of SCr compared with placebo or no treatment (low certainty).
Tonsillectomy plus standard care may leads to lower relapse of proteinuria compared with standard care (low certainty).
The review found no eligible studies for this question.
Renin‐angiotensin system inhibition showed no clear difference in remission of proteinuria: complete remission compared with placebo or no treatment (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether renin‐angiotensin system inhibition changes kidney failure compared with other supportive care treatment (very low certainty).
Angiotensin‐converting‐enzyme inhibitors showed no clear difference in all‐cause death Median compared with placebo or no treatment (low certainty).
Angiotensin receptor blockers may leads to lower doubling of SCr Median compared with placebo or no treatment (low certainty).